S. Kasper and H. Schubert, “Ginkgo Biloba Extract EGb 761? in the Treatment of Dementia: Evidence of Efficacy and Tolerability [Ginkgo-Spezialextrakt EGb 761? in der Behandlung der Demenz: Evidenz für Wirksamkeit und Vertr?glichkeit],” Fortschritte der Neurologie Psychiatrie, Vol. 77, No. 9, September 2009, pp. 494-506.
S. Weinmann, S. Roll, C. Schwarzbach, C. Vauth and S. N. Willich, “Effects of Ginkgo Biloba in Dementia: Systematic Review and Meta-Analysis,” BMC Geriatrics, Vol. 10, 2010, p.14.
B. S. Wang, H. Wang, Y. Y. Song, H. Qi, Z. X. Rong, L. Zhang and H. Z. Chen, “Effectiveness of Standardized Ginkgo Biloba Extract on Cognitive Symptoms of Dementia with a Six-Month Treatment: A Bivariate Random Effect Meta-Analysis,” Pharmacopsychiatry, Vol. 43, No. 3, May 2010, pp. 86-91.
T. Crook, R. T. Bartus, S. H. Ferris, P. Whitehouse, G. D. Cohen and S. G. Gershon, “Age-Associated Memory Impairment: Proposed Diagnostic Criteria and Measures of Clinical Change: Report of a National Institute of Mental Health Work Group,” Developmental Neuro -psychology, Vol. 2, No. 4, 1986, pp. 261-276.
R. C. Blackford and A. La Rue, “Criteria for Diagnosing Age-Associated Memory Impairment: Proposed Improvement from the Field,” Developmental Neuropsychology, Vol. 5, No. 4, 1989, pp. 295-306.
R. Levy and the Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization, “Report: Aging-Associated Cognitive Decline,” International Psychogeriatrics, Vol. 6, No. 1, Spring 1994, pp. 63-68.
E. M. Ebly, D. B. Hogan and I. M. Parhad, “Cognitive Impairment in the Nondemented Elderly; Results from the Canadian Study of Health and Aging,” Archives of Neurology, Vol. 52, No. 6, June 1995, pp. 612-619.
M. Zaudig, “A New Systematic Method of Measurement and Diagnosis of ‘Mild Cognitive Impairment’ and De-Mentia According to Icd-10 and DSM-III-R Criteria,” International Psychogeriatrics, Vol. 4, No. S2, 1992, pp. 203-219.
R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. F. Tangalos and E. Kokmen, “Mild Cognitive Impairment; Clinical Characterization and Outcome,” Archives of Neurology, Vol. 56, No. 3, March 1999, pp. 303-308.
R. C. Petersen, R. Doody, A. Kurz, R. C. Mohs, J. C. Morris, P. V. Rabins, K. Ritchie, M. Rossor, L. Thal and B. Winblad, “Current Concepts in Mild Cognitive Impairment,” Archives of Neurology, Vol. 58, No. 12, December 2001, pp. 1985-1992.
M. Zaudig, “Mild Cognitive Impairment in the Elderly,” Current Opinion in Psychiatry, Vol. 15, No. 4, 2002, pp. 387-393.
H. Wolf, M. Grunwald, G. M. Ecke, D. Zedlick, S. Bettin, C. Dannenberg, J. Dietrich, K. Eschrich, T. Arendt and H. J. Gertz, “The Prognosis of Mild Cognitive Impairment in the Elderly,” Journal of Neural Transmission Supplements, Vol. 54, 1998, pp. 31-50.
J. C. Morris, M. Storandt, P. Miller, D. W. McKeel, J. L. Price, E. H. Rubin and L. Berg, “Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease,” Archives of Neurology, Vol. 58, No. 3, March 2001, pp. 397-405.
S. Larrieu, L. Letenneur, J. M. Orgogozo, C. Fabrig- oule, H. Amieva, N. Le Carret, P. Barberger-Gateau and J. F. Dartigues, “Incidence and Outcome of Mild Cognitive Impairment in a Population-Based Prospec -tive Cohort,” Neurology, Vol. 59, No. 10, November 2002, pp. 1594-1599.
G. Smith, “Is Mild Cognitive Impairment Bridging the Gap between Normal Aging and Alzheimer’s Disease?” Journal of Neural Transmission Supplements, Vol. 62, No. 2, 2002, pp. 97-104.
M. F. Elias, A. Beiser, P. A. Wolf, R. Au, R. F. White and R. B. D’Agostino, “The Preclinical Phase of Alzheimer Disease; A 22-Year Prospective Study of the Framingham Cohort,” Archives of Neurology, Vol. 57, No. 6, June 2000, pp. 808-813.
A. Collie, P. Maruff, R. Shafiq-Antonacci, M. Smith, M. Hallup, P. R. Schofield, C. L. Masters and J. Currie, “Memory Decline in Healthy Older People; Implications for Identifying Mild Cognitive Impairment,” Neurology, Vol. 56, No. 11, June 2001, pp. 1533-1538.
C. H. Kawas, M. M. Corrada, R. Brookmeyer, A. Morrison, S. M. Resnick, A. B. Zonderman and D. Arenberg, “Visual Memory Predicts Alzheimer’s Disease More than a Decade before Diagnosis,” Neuorology, Vol. 60, No. 7, April 2003, pp. 1089-1093.
T. Dwolatzky, V. Whitehead, G. M. Doniger, E. S. Simon, A. Schweiger, D. Jaffe and H. Chertkow, “Validity of a Novel Computerized Cognitive Battery for Mild Cognitive Impairment,” BMC Geriatrics, Vol. 3,
No. 1, November 2003, p. 4. http://www.biomedcentral.com/1471-2318/3/4
B. Schmand, C. Jonker, M. I. Geerlings and J. Linde -boom, “Subjective Memory Complaints in the Elderly: Depressive Symptoms and Future Dementia,” British Journal of Psychiatry, Vol. 171, October 1997, pp. 373-376.
P. W. Schofield, K. Marder, G. Dooneief, D. Jacobs, M. Sano and Y. Stern, “Association of Subjective Memory Complaints with Subsequent Cognitive Decline in Community-Dwelling Elderly Individuals with Baseline Cognitive Impairment,” American Journal of Psychiatry, Vol. 154, No. 5, May 1997, pp. 609-615.
P. W. Schofield, D. Jacobs, K. Marder, M. Sano and Y. Stern, “The Validity of New Memory Complaints in the Elderly,” Archives of Neurology, Vol. 54, No. 6, June 1997, pp. 756-759.
M. I. Geerlings, C. Jonker, L. M. Bouter, H. J. Adèr and B. Schmand, “Association between Memory Com- Plaints and Incident Alzheimer’s Disease in Elderly People with Normal Baseline Cognition,” American Journal of Psychiatry, Vol. 156, No. 4, April 1999, pp. 531-537.
A. K. Berger, L. Fratiglioni, Y. Forsell, B. Winblad and L. B?ckman, “The Occurrence of Depressive Symptoms in the Preclinical Phase of AD; A Population-Based Study,” Neurology, Vol. 53, No. 9, December 1999, pp. 1998-2002.
N. Rasgon and L. Jarvik, “Insulin Resistance May Link Affective Disorders and Alzheimer’s Disease: A Missing Link Hypothesis,” International Psychogeriatrics, Vol. 15, No. S2, August 2003, p. 153 (Abstract S071- 005).
C. G. Lyketsos, O. Lopez, B. Jones, A. L. Fitzpatrick, J. Breitner and S. T. DeKosky, “Prevalence of Neuro- Psychiatric Symptoms in Dementia and Mild Cognitive Impairment; Results from the Cardiovascular Health Study,” Journal of the American Medical Association,
Vol. 288, No. 12, September 2002, pp. 1475-1483. http://jama.ama-assn.org/cgi/content/full/288/12/1475
D. C. Chan, J. D. Kasper, B. S. Black and P. V. Rabins, “Prevalence and Correlates of Behavioral and Psychiat -ric Symptoms in Community-Dwelling Elders with De-Mentia or Mild Cognitive Impairment: The Memory and Medical Care Study,” International Journal of Geriatric Psychiatry, Vol. 18, No. 2, February 2003, pp. 174-182.
Y. Forsell, K. Palmer and L. Fratiglioni, “Psychiatric Symptoms/Syndromes in Elderly Persons with Mild Cognitive Impairment; Data from a Cross-Sectional Study,” Acta Neurologica Scandinavica, Vol. 107, No. S179, 2003, pp. 25-28.
D. Wechsler, “WMS-III Administration and Scoring Manual,” The Psychological Corporation, San Antonio, 1997.
W. Neuwirth and M. Benesch, “Arbeitsleistungsserie Version 25.00; Handanweisung,” Schuhfried, M?dling, 2004.
W. Neuwirth and M. Benesch, “Wiener Determina -tionstest Version 31.00; Handanweisung,” Schuhfried, M?dling, 2005.
D. von Zerssen, “Clinical Self-Rating Scales (CSRS) of the Munich Psychiatric Information System (PSYCHIS München),” In: N. Sartorius and T. A. Ban, Eds., Assessment of Depression, Springer, Berlin, 1986, pp. 270-303.
J. E. Ware, K. K. Snow, M. Kosinski and B. Gandek, “SF-36 Health Survey Manual and Interpretation Guide.” New England Medical Center, the Health Institute, Boston, 1993.
A. E. Zehnder, S. Bl?si, M. Berres, R. Spiegel and A. U. Monsch, “Lack of Practice Effects on Neuropsychological Tests as Early Cognitive Markers of Alzheimer Disease?” American Journal of Alzheimer’s Disease & Other Dementias, Vol. 22, No. 5, October-November 2007, pp. 416-426.
H. Schubert and P. Halama, “Depressive Episode Primarily Unresponsive to Therapy in Elderly Patients: Efficacy of Ginkgo Biloba Extract EGb 761? in Combination with Antidepressants [Prim?r therapieresistente depressive Verstimmung ?lterer Patienten mit Hirnleistungsst?rungen: Wirksamkeit der Kombination von Ginkgo-biloba-Extrakt EGb 761? mit Antidepres- siva],” Geriatrie Forschung, Vol. 3, No. 1, 1993, pp. 45-53.
U. Stocksmeier and M. Eberlein, “Depression Associated with Impairment of Cerebral Function; Effects of a Ginkgo Biloba Extract Investigated in Double-Blind Trial [Depressive Verstimmung bei Hirnleistungsst?rungen; Wirkung eines Ginkgo-biloba-Extraktes in Doppelblind-Studieüberprüft],” TW Neurologie Psychiatrie, Vol. 6, January-February 1992, pp. 74-76.